Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery

NCT01639833 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.

NCT NCT01639833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01639833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery
Lead sponsor
Medtronic - MITG
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2012
Completion date
December 31, 2013
Enrollment
90 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgical procedures, hemorrhage